Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Virtual Event
Real-Life Robocop Webinar: Meeting 'Impossible' RTW Goals in Catastrophic Cases
On-Demand
When workers survive a catastrophic injury, they often sustain significant injuries that prevent them from returning to work.
Workers' Comp
News Release
Risk & Insurance: Empowering Injured Workers to Heal
Educating injured workers provides them with a sense control over their care and their recovery.
Auto Physical Damage
News Release
Mitchell’s 17th Annual AutocheX Premier Achiever Awards Honors Industry's Best Repair Facilities
Industry Leaders Honored for Commitment to Operational Excellence and Superior Customer Satisfaction
Mitchell
Article
Pharmacy Management: A Proactive Approach
Mitchell
News Release
Mitchell’s 17th Annual AutocheX™ Premier Achiever Awards Honors Industry's Best Repair Facilities
Industry Leaders Honored for Commitment to Operational Excellence and Superior Customer Satisfaction
Workers' Comp
Blog
Drops in MED Indicate We’re Making Important Progress
Part One of Coventry’s 2017 Drug Trends Series reported the largest drop in Morphine Equivalent Dose (MED) in the last three years.